Aspirin use and breast cancer risk: A meta-analysis

Breast Cancer Research and Treatment

Volumn 131, Issue 2, 2012, Pages 581-587

  Luo, Ting ^a   Yan, Hua Mei ^a   He, Ping ^a   Luo, Yong ^a   Yang, Yuan Fu ^a   Zheng, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Aspirin; Breast cancer; Meta analysis

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; RISK;

EID: 84856209998     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1747-0     Document Type: Article

References (59)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 1 43 66 17237035 10.3322/canjclin.57.1.43 (Pubitemid 46148091)
2. HB Muss DA Berry CT Cirrincione M Theodoulou AM Mauer AB Kornblith AH Partridge LG Dressler HJ Cohen HP Becker PA Kartcheske JD Wheeler EA Perez AC Wolff JR Gralow HJ Burstein AA Mahmood G Magrinat BA Parker RD Hart D Grenier L Norton CA Hudis EP Winer 2009 Adjuvant chemotherapy in older women with early-stage breast cancer N Engl J Med 360 20 2055 2065 19439741 1:CAS:528:DC%2BD1MXmtVagsbw%3D 10.1056/NEJMoa0810266
3. RT Chlebowski GL Blackburn CA Thomson DW Nixon A Shapiro MK Hoy MT Goodman AE Giuliano N Karanja P McAndrew C Hudis J Butler D Merkel A Kristal B Caan R Michaelson V Vinciguerra S Del Prete M Winkler R Hall M Simon BL Winters RM Elashoff 2006 Dietary fat reduction and breast cancer outcome: interim efficacy results from the women's intervention nutrition study J Natl Cancer Inst 98 24 1767 1776 17179478 10.1093/jnci/djj494 (Pubitemid 46017928)
4. MD Holmes WY Chen L Li E Hertzmark D Spiegelman SE Hankinson 2010 Aspirin intake and survival after breast cancer J Clin Oncol 28 9 1467 1472 20159825 1:CAS:528:DC%2BC3cXltFGhsLw%3D 10.1200/JCO.2009.22.7918
5. YS Zhao S Zhu XW Li F Wang FL Hu DD Li WC Zhang X Li 2009 Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis Breast Cancer Res Treat 117 1 141 150 18979210 1:CAS:528:DC%2BD1MXpvFyiurY%3D 10.1007/s10549-008-0228-6
6. B Takkouche C Regueira-Mendez M Etminan 2008 Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis J Natl Cancer Inst 100 20 1439 1447 18840819 1:CAS:528:DC%2BD1cXht1Oisb7I 10.1093/jnci/djn324
7. SA Khuder AB Mutgi 2001 Breast cancer and NSAID use: a meta-analysis Br J Cancer 84 9 1188 1192 11336469 1:CAS:528:DC%2BD3MXkt1Olurc%3D 10.1054/bjoc.2000.1709 (Pubitemid 32511336)
8. S Mangiapane M Blettner P Schlattmann 2008 Aspirin use, breast cancer risk: a meta-analysis, meta-regression of observational studies from 2001 to 2005 Pharmacoepidemiol Drug Saf 17 2 115 124 17955496 10.1002/pds.1503 (Pubitemid 351308510)
9. S Greenland 1987 Quantitative methods in the review of epidemiologic literature Epidemiol Rev 9 1 30 3678409 1:STN:280:DyaL1c%2FlsFCgtg%3D%3D
10. J Robins S Greenland NE Breslow 1986 A general estimator for the variance of the Mantel-Haenszel odds ratio Am J Epidemiol 124 5 719 723 3766505 1:STN:280:DyaL2s%2Fit12msw%3D%3D (Pubitemid 17180485)
11. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 629 634 9310563 1:STN:280:DyaK2svls1KjtA%3D%3D 10.1136/bmj.315.7109.629 (Pubitemid 27387172)
12. CB Begg M Mazumdar 1994 Operating characteristics of a rank correlation test for publication bias Biometrics 50 4 1088 1101 7786990 1:STN:280: DyaK2Mzgs1GrtQ%3D%3D 10.2307/2533446
13. A Bardia JE Olson CM Vachon D Lazovich RA Vierkant AH Wang PJ Limburg KE Anderson JR Cerhan 2011 Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study Breast Cancer Res Treat 126 1 149 155 20669045 1:CAS:528: DC%2BC3MXpvFWgtw%3D%3D 10.1007/s10549-010-1074-x
14. DP Cronin-Fenton L Pedersen TL Lash S Friis JA Baron HT Sorensen 2010 Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study Breast Cancer Res 12 2 R15 20193065 10.1186/bcr2482
15. TM Brasky MR Bonner KB Moysich CB Ambrosone J Nie MH Tao SB Edge BV Kallakury C Marian M Trevisan PG Shields JL Freudenheim 2010 Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the western New York exposures and breast cancer (WEB) study Cancer Causes Control 21 9 1503 1512 20499154 10.1007/s10552-010-9579-5
16. AH Eliassen WY Chen D Spiegelman WC Willett DJ Hunter SE Hankinson 2009 Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the nurses' health study II Arch Intern Med 169 2 115 121 19171806 10.1001/archinternmed.2008.537 Discussion: 121
17. S Friis L Thomassen HT Sorensen A Tjonneland K Overvad DP Cronin-Fenton U Vogel JK McLaughlin WJ Blot JH Olsen 2008 Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study Eur J Cancer Prev 17 2 88 96 18287865 10.1097/CEJ.0b013e3282b6fd55 (Pubitemid 351301619)
18. A Ready CM Velicer A McTiernan E White 2008 NSAID use and breast cancer risk in the VITAL cohort Breast Cancer Res Treat 109 3 533 543 17674199 1:CAS:528:DC%2BD1cXlvVCgtrY%3D 10.1007/s10549-007-9665-x (Pubitemid 351692052)
19. GL Gierach JV Lacey Jr A Schatzkin MF Leitzmann D Richesson AR Hollenbeck LA Brinton 2008 Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study Breast Cancer Res 10 2 R38 18447943 10.1186/bcr2089
20. JK Gill G Maskarinec LR Wilkens MC Pike BE Henderson LN Kolonel 2007 Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort Am J Epidemiol 166 10 1150 1158 17698973 10.1093/aje/kwm195 (Pubitemid 350022753)
21. EJ Jacobs MJ Thun EB Bain C Rodriguez SJ Henley EE Calle 2007 A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence J Natl Cancer Inst 99 8 608 615 17440162 1:CAS:528: DC%2BD2sXlvVSksbY%3D 10.1093/jnci/djk132 (Pubitemid 47073542)
22. ML Slattery K Curtin R Baumgartner C Sweeney T Byers AR Giuliano KB Baumgartner RR Wolff 2007 IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States Cancer Epidemiol Biomarkers Prev 16 4 747 755 17416766 1:CAS:528:DC%2BD2sXjvV2msrw%3D 10.1158/1055-9965.EPI-06-0667 (Pubitemid 46650577)
23. L Gallicchio K Visvanathan A Burke SC Hoffman KJ Helzlsouer 2007 Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD Int J Cancer 121 1 211 215 17330846 1:CAS:528:DC%2BD2sXlsVajs7Y%3D 10.1002/ijc.22656 (Pubitemid 46753870)
24. RE Harris J Beebe-Donk GA Alshafie 2006 Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors BMC Cancer 6 27 16445867 10.1186/1471-2407-6-27 (Pubitemid 43264309)
25. SF Marshall L Bernstein H Anton-Culver D Deapen PL Horn-Ross H Mohrenweiser D Peel R Pinder DM Purdie P Reynolds D Stram D West WE Wright A Ziogas RK Ross 2005 Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status J Natl Cancer Inst 97 11 805 812 15928301 1:CAS:528:DC%2BD2MXkvVShtbY%3D 10.1093/jnci/dji140 (Pubitemid 40909123)
26. Y Zhang PF Coogan JR Palmer BL Strom L Rosenberg 2005 Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the case-control surveillance study revisited Am J Epidemiol 162 2 165 170 15972932 10.1093/aje/kwi182 (Pubitemid 41373542)
27. H Swede AL Mirand RJ Menezes KB Moysich 2005 Association of regular aspirin use and breast cancer risk Oncology 68 1 40 47 15802928 1:CAS:528:DC%2BD2MXjslCgtbs%3D 10.1159/000084818 (Pubitemid 40675007)
28. E Rahme J Ghosn K Dasgupta R Rajan M Hudson 2005 Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer BMC Cancer 5 159 16343343 10.1186/1471-2407-5-159 (Pubitemid 41829857)
29. NR Cook IM Lee JM Gaziano D Gordon PM Ridker JE Manson CH Hennekens JE Buring 2005 Low-dose aspirin in the primary prevention of cancer: the women's health study: a randomized controlled trial JAMA 294 1 47 55 15998890 1:CAS:528:DC%2BD2MXlvVKnt7Y%3D 10.1001/jama.294.1.47 (Pubitemid 41002838)
30. LA Garcia Rodriguez A Gonzalez-Perez 2004 Risk of breast cancer among users of aspirin and other anti-inflammatory drugs Br J Cancer 91 3 525 529 15226764 1:CAS:528:DC%2BD2cXlvF2ltro%3D 10.1038/sj.bjc.6602003 (Pubitemid 39093573)
31. MB Terry MD Gammon FF Zhang H Tawfik SL Teitelbaum JA Britton K Subbaramaiah AJ Dannenberg AI Neugut 2004 Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk JAMA 291 20 2433 2440 15161893 1:CAS:528:DC%2BD2cXksVehurk%3D 10.1001/jama.291.20.2433 (Pubitemid 38669186)
32. LD Ratnasinghe BI Graubard L Kahle JA Tangrea PR Taylor E Hawk 2004 Aspirin use and mortality from cancer in a prospective cohort study Anticancer Res 24 5B 3177 3184 15510608 (Pubitemid 39390970)
33. PG Moorman JM Grubber RC Millikan B Newman 2003 Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast Cancer Causes Control 14 10 915 922 14750530 10.1023/B:CACO.0000007973.59863.66 (Pubitemid 38091212)
34. RE Harris RT Chlebowski RD Jackson DJ Frid JL Ascenseo G Anderson A Loar RJ Rodabough E White A McTiernan 2003 Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the women's health initiative Cancer Res 63 18 6096 6101 14522941 1:CAS:528:DC%2BD3sXnvVSitb8%3D (Pubitemid 37187516)
35. TW Johnson KE Anderson D Lazovich AR Folsom 2002 Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer Cancer Epidemiol Biomarkers Prev 11 12 1586 1591 12496048 1:CAS:528:DC%2BD3sXmsF2mug%3D%3D (Pubitemid 36020011)
36. M Cotterchio N Kreiger M Sloan A Steingart 2001 Nonsteroidal anti-inflammatory drug use and breast cancer risk Cancer Epidemiol Biomarkers Prev 10 11 1213 1217 11700271 1:CAS:528:DC%2BD3MXptFWqu7Y%3D (Pubitemid 33064311)
37. RE Harris S Kasbari WB Farrar 1999 Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer Oncol Rep 6 1 71 73 9864404 1:CAS:528:DyaK1MXkt1SjtA%3D%3D
38. PF Coogan SR Rao L Rosenberg JR Palmer BL Strom AG Zauber PD Stolley S Shapiro 1999 The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer Prev Med 29 2 72 76 10446030 1:CAS:528:DyaK1MXltV2hsL8%3D 10.1006/pmed.1999.0518 (Pubitemid 29406779)
39. AI Neugut DJ Rosenberg H Ahsan JS Jacobson N Wahid M Hagan MI Rahman ZR Khan L Chen A Pablos-Mendez S Shea 1998 Association between coronary heart disease and cancers of the breast, prostate, and colon Cancer Epidemiol Biomarkers Prev 7 10 869 873 9796631 1:STN:280:DyaK1M%2FhtVKmtw%3D%3D (Pubitemid 28471574)
40. KM Egan MJ Stampfer E Giovannucci BA Rosner GA Colditz 1996 Prospective study of regular aspirin use and the risk of breast cancer J Natl Cancer Inst 88 14 988 993 8667430 1:STN:280:DyaK283osFGmtQ%3D%3D 10.1093/jnci/88.14.988 (Pubitemid 26239387)
41. RE Harris KK Namboodiri WB Farrar 1996 Nonsteroidal antiinflammatory drugs and breast cancer Epidemiology 7 2 203 205 8834563 1:STN:280: DyaK28vjtFCrsw%3D%3D 10.1097/00001648-199603000-00017 (Pubitemid 26068056)
42. DM Schreinemachers RB Everson 1994 Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 2 138 146 8172988 1:STN:280:DyaK2c3islWmsw%3D%3D 10.1097/00001648-199403000-00003 (Pubitemid 24073387)
43. MJ Thun MM Namboodiri EE Calle WD Flanders CW Heath Jr 1993 Aspirin use and risk of fatal cancer Cancer Res 53 6 1322 1327 8443812 1:CAS:528: DyaK3sXktl2qtLY%3D (Pubitemid 23097110)
44. A Paganini-Hill A Chao RK Ross BE Henderson 1989 Aspirin use and chronic diseases: a cohort study of the elderly BMJ 299 6710 1247 1250 2513898 1:STN:280:DyaK3c7gsFyiug%3D%3D 10.1136/bmj.299.6710.1247 (Pubitemid 19280046)
45. GD Friedman HK Ury 1980 Initial screening for carcinogenicity of commonly used drugs J Natl Cancer Inst 65 4 723 733 6932525 1:STN:280: DyaL3M%2FivVOhtg%3D%3D (Pubitemid 10059961)
46. DA Corley K Kerlikowske R Verma P Buffler 2003 Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis Gastroenterology 124 1 47 56 12512029 1:CAS:528:DC%2BD3sXot1ansQ%3D%3D 10.1053/gast.2003.50008 (Pubitemid 36055338)
47. FV Din E Theodoratou SM Farrington A Tenesa RA Barnetson R Cetnarskyj L Stark ME Porteous H Campbell MG Dunlop 2010 Effect of aspirin and NSAIDs on risk and survival from colorectal cancer Gut 59 12 1670 1679 20844293 1:CAS:528:DC%2BC3MXpvFei 10.1136/gut.2009.203000
48. PM Rothwell M Wilson CE Elwin B Norrving A Algra CP Warlow TW Meade 2010 Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Lancet 376 9754 1741 1750 20970847 1:CAS:528:DC%2BC3cXhsVGitbfF 10.1016/S0140-6736(10)61543-7
49. AT Chan S Ogino CS Fuchs 2007 Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 N Engl J Med 356 21 2131 2142 17522398 1:CAS:528:DC%2BD2sXlvVersr0%3D 10.1056/NEJMoa067208 (Pubitemid 47010839)
50. P Yang Y Zhou B Chen HW Wan GQ Jia HL Bai XT Wu 2010 Aspirin use and the risk of gastric cancer: a meta-analysis Dig Dis Sci 55 6 1533 1539 19672710 1:CAS:528:DC%2BC3cXntlais70%3D 10.1007/s10620-009-0915-0
51. PM Rothwell FG Fowkes JF Belch H Ogawa CP Warlow TW Meade 2011 Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 9759 31 41 21144578 1:CAS:528:DC%2BC3MXms1Wk 10.1016/S0140-6736(10)62110-1
52. PK Dhillon SA Kenfield MJ Stampfer EL Giovannucci 2011 Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006 Int J Cancer 128 10 2444 2452 21128233 1:CAS:528:DC%2BC3MXjvVSktLs%3D 10.1002/ijc.25811
53. CA Salinas EM Kwon LM FitzGerald Z Feng PS Nelson EA Ostrander U Peters JL Stanford 2010 Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk Am J Epidemiol 172 5 578 590 20688905 10.1093/aje/kwq175
54. EJ Jacobs C Rodriguez AM Mondul CJ Connell SJ Henley EE Calle MJ Thun 2005 A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence J Natl Cancer Inst 97 13 975 980 15998950 10.1093/jnci/dji173 (Pubitemid 41430563)
55. TJ Powles SA Clark DM Easty GC Easty AM Neville 1973 The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer Br J Cancer 28 4 316 321 4759939 1:CAS:528:DyaE2cXhtVCrug%3D%3D 10.1038/bjc.1973.154
56. C Sotiriou M Lacroix L Lagneaux G Berchem JJ Body 1999 The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11 Anticancer Res 19 4B 2997 3006 10652584 1:CAS:528:DC%2BD3cXmvF2msg%3D%3D (Pubitemid 30042582)
57. G Abbadessa A Spaccamiglio ML Sartori C Nebbia M Dacasto F Di Carlo S Racca 2006 The aspirin metabolite, salicylate, inhibits 7, 12-dimethylbenz[a] anthracene-DNA adduct formation in breast cancer cells Int J Oncol 28 5 1131 1140 16596229 1:CAS:528:DC%2BD28Xks1Cju7k%3D
58. LF Alfonso KS Srivenugopal TV Arumugam TJ Abbruscato JA Weidanz GJ Bhat 2009 Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells Int J Oncol 34 3 597 608 19212664 1:CAS:528:DC%2BD1MXjs1Kgsrg%3D
59. M Bhattacharyya GV Girish R Ghosh S Chakraborty AK Sinha 2010 Acetyl salicylic acid (aspirin) improves synthesis of maspin and lowers incidence of metastasis in breast cancer patients [corrected] Cancer Sci 101 10 2105 2109 20670296 1:CAS:528:DC%2BC3cXhtlegtrjL 10.1111/j.1349-7006.2010.01655.x